3[1]Chang RS, Lotti VJ. Angiotensin receptor subtypes in rat,rabbit and monkey tissues: Relative distribution and species dependency. Life Sci, 1991,49: 1485-1490
5[3]Ardaillou R, Sraer J, Chansel D, et al. The effects of angiotention Ⅱ on isolated glomeruli and cultured glomerular cell. Kidney Int, 1987,31: S74-80
6[4]Nunez E, Hosoga K, Susic D, et al. Enalapril and Losartan reduced cardiac mass and improred coronary hemodynamic in SHK. Hypertention, 1997,29:519-524
7[5]Kagami S, Border WA, Miller DE, et al. Angiotention Ⅱ stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cell. J Clin Invest, 1994,93:2431
8[6]Arai M, Wada A, Isaka Y, et al. In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induce phenotypic change of the messangial cells and glomemlosclerosis. Biochem Biophys Res Commun,1995,206: 525-532
9[7]Stoll M, Steckelings M, Paul M, et al. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary edothelial cells. J Clin Invest, 1995,95: 651-657
10[8]Tsuzuki S, Matobu T,Eguchi S, et al. Angiotensin Ⅱ type Ⅰ receptor inhibits cell proliferation and activates tyrosine phophatase. Hypertention,1996,28:916-918
8Weber M A, Byyny R L, Pratt H, et al. Blood pressure effects of the angiotensin Ⅱ receptor blocker, losartan[J]. Arch Intern Med, 1995, 155:405-411.
9Mallion M. Antihypertensive efficacy and tolerbility of once daily losartan compared with captopril in patients with mild to moderate essential hypertension[J]. Hypertension, 1995, 13(suppl):S35-S41.
10Neutel J, Weber M, Pool J, et al. Valsartan, a new antiotensin Ⅱ antagonist: antihypertensive effects over 24 hours[J]. Clin Ther, 1997, 19(3):447-458.
